Belgium· BE-AMP-SAM211617-00
Agippal 0.5 ml
A influenza, inaktiviert, spalt/split virus oder oberflächen-antigen product containing influenzae virus (inactive), registered in Belgium by Seqirus. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BB02 (influenza, inaktiviert, spalt/split virus oder oberflächen-antigen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen · ATC J07BB02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Influenzae Virus (Inactive)
- Manufacturer
- Seqirus
- Country
- Belgium (BE)
- ATC code
- J07BB02
- ATC class
- Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2929503
- be_apb0759753
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BB02
Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen, as other registers publish it.
- PolandAdjupanrixGlaxoSmithKline Biologicals S.A.
- DenmarkAdjupanrixGlaxoSmithKline Biologicals S.A.
- BelgiumAdjupanrixGlaxoSmithKline Biologicals
- IcelandAdjupanrixGlaxoSmithKline Biologicals S.A.*
- FinlandAdjupanrixGlaxoSmithKline Biologicals SA
- CzechiaADJUPANRIXGlaxoSmithKline Biologicals S.A., Rixensart
- IrelandAdjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.
- NetherlandsAdjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieGlaxoSmithKline Biologicals S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbd47d3e-c6e8-4e72-8b12-513b3c661678 GET /v1/drugs/cbd47d3e-c6e8-4e72-8b12-513b3c661678?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspension for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Agippal 0.5 ml",
"name_fr": "Agippal 0.5 ml",
"name_nl": "Agippal 0.5 ml",
"amp_code": "SAM211617-00",
"strengths": null,
"pack_count": 4,
"substances": [
"Influenzae Virus (Inactive)"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Influenza, Inactivated, Split Virus Or Surface Antigen",
"authorisation_numbers": [
"BE211617"
]
}See everything about influenza, inaktiviert, spalt/split virus oder oberflächen-antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.